The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- The Role of Media in Good Governance: Fostering Citizens’ Engagement and Participation
- NITDA partners Flutterwave, Alami to promote digital transformation
- [EXPLAINER] What are the truth about dietary fat?
- Spinal cord association unveils policy to support PwDs
- NiMet predicts sunshine, haziness from Saturday
- FG plans revitalization of veterinary institute to meet vaccine needs
- Nigeria plans establishment of gene bank to preserve local livestock breeds
- Coconut traders task farmers on high-quality seedlings